Aging Immune System and the Brain: Strong in Mice, Thin in Humans
Graded Preliminary — the paper summarizes existing knowledge and adds no new data of its own; many of the findings it covers come from animal experiments.
- Design
- Narrative review
- Participants
- N/A
- Duration
- —
- Funding
- Next Generation EU
Evidence that an aging immune system harms the brain comes mainly from animal experiments; in humans it is mostly a link so far.
As people age, the immune system changes, and a low, lasting inflammation often settles in the body. Experts increasingly see this as a central driver of diseases in which nerve cells die, such as Alzheimer's, Parkinson's and multiple sclerosis. A review gathers what is known so far.
In the brain, aging immune and support cells lose their protective role. In people, the evidence is mostly about links: those with higher inflammation markers in their blood in midlife showed greater mental decline later. Treatments show a mixed picture. Two drugs that target aged cells, dasatinib and quercetin, did not clearly improve thinking in a small early trial in people with Alzheimer's. In Parkinson's, one stool transplant from healthy donors eased movement problems for 12 months in one trial.
The authors themselves stress that cause and effect is mainly shown in animal experiments. Reliable blood tests that measure immune aging in humans are still missing. Most of the treatment ideas remain at an early stage.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.